BTIG Research has restarted coverage on the following:
Abbott (NYSE:ABT): Neutral.
Abiomed (NASDAQ:ABMD): Neutral.
AtriCure (NASDAQ:ATRC): Buy with $42 (9% upside) price target.
Boston Scientific (NYSE:BSX): Buy with $46 (8% upside) price target.
Edwards Lifesciences (NYSE:EW): Neutral.
Neuronetics (NASDAQ:STIM): Buy with $11 (199% upside).
IRhythm (NASDAQ:IRTC): Buy with $90 (1% upside).
https://seekingalpha.com/news/3539120-btig-resumes-coverage-on-range-of-healthcare-stocks-neutral-on-abbvie
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.